More from YCHARTS
Referenced Stocks

China Drug Market to Boom – Diabetes Alone a $3.2 Billion Business by 2016

By YCHARTS,  November 05, 2012, 05:50:22 PM EDT

China's pharmaceuticals market is expected to grow at a 15-to-18% pace through 2016, totaling $165 billion by the end of that period, with roughly $3.2 billion spent on diabetes drugs, Bloomberg reported.

The companies to benefit from the growing treatment if diabetes in China include Merck ( MRK ), Sanofi ( SNY ) and Novo Nordisk ( NVO ).

The drug industry in general is struggling to produce revenue growth, in the wake of patent expirations on blockbuster drugs and the discovery of too few new drugs.

MRK Revenue TTM data by YCharts

Bloomberg quoted the International Diabetes Federation as estimating that just $194 a year is spent treating the average diabetes patient in China, while more than $5,000 is spent helping each U.S. patient. Any narrowing of that gap would help drug makers, it seems.

From the editors of YCharts, which includes the just-released YCharts Pro Platinum for professional investors.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: investing, Stocks

Referenced Stocks: MRK, NVO, SNY



Latest News Video

London Hotel Offers 24-Karat Gold Tea
London Hotel Offers 24-Karat Gold T...
Man Accused of Assaulting Girlfriend With Tongs and Meat
Man Accused of Assaulting Girlfrien...
80-Year-Old Man Is the Oldest to Climb Mt. Everest
80-Year-Old Man Is the Oldest to Cl...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.24 0.03  0.23%
FB $ 24.32 0.74  2.95%
SIRI $ 3.58 0.04  0.99%
GE $ 23.53 0.13  0.55%
PFE $ 29.04 0.07  0.24%
MSFT $ 34.27 0.12  0.35%
INTC $ 23.93 0.12  0.50%
P $ 16.43 0.73  4.25%